raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:480541

High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement

Type
Disease
Group
Disorder
Inheritance
Not applicable
Status
active

A rare aggressive B-cell non-Hodgkin lymphoma characterized by a rearrangement in MYC and BCL2 and/or BCL6 (so-called double-hit or triple-hit lymphoma). The category includes double-hit cases with features intermediate between diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma, blastoid cases with a double-hit, and cases with a DLBCL, not otherwise specified, morphology with a double-hit. It refers only to <i>de novo</i> cases, not to lymphomas with a history of pre-existing or coexistent indolent lymphoma. Patients typically present with widespread disease, including involvement of lymph nodes, bone marrow, and central nervous system.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enHigh grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement
frLymphome B d'évolution agressive avec un réarrangement de MYC et/ou BCL2 et/ou BCL6
deHochmalignes B-Zell-Lymphom mit Rearrangement von MYC und/oder BCL2 und/oder BCL6
esLinfoma de células B de alto grado con reordenamientos de MYC y BCL2 y/o BCL6
itLinfoma a cellule B ad alto grado di malignità con riarrangiamenti di MYC e/o BCL2 e/o BCL6
nlHooggradig B-cellymfoom met herschikkingen van MYC en BCL2 en/of BCL6
ptLinfoma de células B de evolução agressiva com rearranjo de MYC e/ou BCL2 e/ou BCL6
plChłoniak z komórek B z rearanżacją MYC i(lub) BCL2 i(lub) BCL6 o wysokim stopniu złośliwości
csHigh grade B-lymfom s MYC a/nebo BCL2 a/nebo BCL6 přestavbou
ukВисокодиференційована В-клітинна лімфома з перебудовою MYC та/або BCL2 та/або BCL6
zh高级别B细胞淋巴瘤合并MYC/BCL2/BLC6重排
trMYC ve/veya BCL2 ve/veya BCL6 yeniden düzenlemesine sahip yüksek seviyede B hücreli lenfoma

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C85.7NTBTattributedvalidated
MONDO0018813Evalidated
UMLSC4524190Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

3 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
BCL2Part of a fusion gene inAssessedHGNC:990ENSG0000017179115143018q21.33BCL2 apoptosis regulator21119107[PMID]_27888878[PMID]_27717585[PMID]
BCL6Part of a fusion gene inAssessedHGNC:1001ENSG000001139161095653q27.3BCL6 transcription repressor21119107[PMID]_27888878[PMID]_27717585[PMID]
MYCPart of a fusion gene inAssessedHGNC:7553ENSG000001369971900808q24.21MYC proto-oncogene, bHLH transcription factor21119107[PMID]_27888878[PMID]_27717585[PMID]
5

Prevalence and incidence

0 records

No prevalence record in this release.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card